Central IRB

>> Expert Meeting

Collaboration through Innovation

Use of Central IRBs for Multicenter Clinical Trials

April 25 - 26, 2012
Hilton Washington DC/Rockville Executive Meeting Center, Rockville, MD

Project Category: Study Start-UpProject: Central IRB

CLICK HERE for a list of meeting attendees.
CLICK HERE for the meeting agenda.
CLICK HERE for the Executive Summary.

 

Meeting Background

The willingness of institutions to defer full local institutional review board (IRB) review and approval to a central IRB in multicenter trials continues to vary, despite a 2006 U.S. Food and Drug Administration (FDA) guidance and a more recent endorsement by the U.S. Office for Human Research Protections recommending this approach. The goal of the CTTI project is to identify potential solutions to address barriers to the adoption of central IRBs for multicenter clinical trials.

 

Meeting Objectives

  • Present research findings from the CTTI project entitled, Use of Central IRBs for Multicenter Clinical Trials  
  • Discuss research findings among experts present at the meeting
  • Solicit additional feedback to refine proposed solutions

 

Meeting Presentations

 


*The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.